Exchange: NYSE·Updated 06:49 PM EDT
COR logo

CORCencora Inc.

$278.25
$4.48
(1.57%)
Today
Closed $281.65
$3.40
(1.21%)
After Hours
EarningsAug 5
Mkt Cap$55.67B
Vol1.01M
News
all
press releases
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?
Cardinal Health has gained nearly 8% in 2026 as specialty pharma growth, rising EPS, and expanding healthcare services fuel investor optimism.
Zacks
News Placeholder
More News
News Placeholder
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?
COR shares are down 18% YTD, but rising EPS guidance, specialty pharma growth and strategic expansion could make this pullback worth watching.
Zacks
News Placeholder
Cencora Launches Enhanced Nucleus Solution for Specialty Practices
COR's enhanced Nucleus platform targets complex specialty medication workflows, with a pilot underway across more than 20 physician practice sites.
Zacks
News Placeholder
Bet on 5 Top-Ranked Stocks With Rising P/E for Solid Returns
Rising P/E ratios can signal confidence and momentum. Discover 5 stocks backed by strong earnings growth and upside potential.
Zacks
News Placeholder
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. TPR, VRT, CLS and COR are some such stocks.
Zacks
News Placeholder
Cencora Announces Samantha Hammock as Chief Human Resources Officer
Cencora, Inc. (NYSE: COR) today announced that Silvana Battaglia, Executive Vice President and Chief Human Resources Officer (CHRO), has announced she will retire from the company following a distinguished seven-year tenure. She will be succeeded by Samantha (Sam) Hammock, who will join Cencora as...
Business Wire
News Placeholder
Cencora's Specialty Supply Chain: Where COR's Growth Is Headed
COR bets on MSOs, specialty logistics and AI tools to deepen ties beyond distribution???even as GLP-1 mix and pricing swings cloud results.
Zacks
News Placeholder
Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?
Cencora (COR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Wall Street Analysts Predict a 33.55% Upside in Cencora (COR): Here's What You Should Know
The mean of analysts' price targets for Cencora (COR) points to a 33.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR PR Newswire NEW YORK, May 28, 2026 NEW YORK, May 28, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.